107 related articles for article (PubMed ID: 23343657)
41. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
42. Deletions and point mutations of p16,p15 gene in primary tumors and tumor cell lines.
Yonghao T; Qian H; Chuanyuan L; Yandell DW
Chin Med Sci J; 1999 Dec; 14(4):200-5. PubMed ID: 12894891
[TBL] [Abstract][Full Text] [Related]
43. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
44. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
[TBL] [Abstract][Full Text] [Related]
45. Alteration of p16 and p15 genes in human uterine tumours.
Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
[TBL] [Abstract][Full Text] [Related]
46. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.
Zhang S; Endo S; Koga H; Ichikawa T; Feng X; Onda K; Washiyama K; Kumanishi T
Jpn J Cancer Res; 1996 Sep; 87(9):900-7. PubMed ID: 8878451
[TBL] [Abstract][Full Text] [Related]
47. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
48. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
49. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
[TBL] [Abstract][Full Text] [Related]
50. Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells.
Yazawa M; Okuda M; Kanaya N; Hong SH; Takahashi T; Ohashi E; Nakagawa T; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2003 Nov; 64(11):1395-400. PubMed ID: 14620776
[TBL] [Abstract][Full Text] [Related]
51. Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.
Hirai H; Ogawa S; Hangaishi A; Takahashi T; Kurokawa M; Mitani K; Ueda R; Yazaki Y
Leukemia; 1997 Apr; 11 Suppl 3():358-60. PubMed ID: 9209389
[TBL] [Abstract][Full Text] [Related]
52. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H
Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
[TBL] [Abstract][Full Text] [Related]
53. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
54. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
55. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
56. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
[TBL] [Abstract][Full Text] [Related]
57. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
58. Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.
Sakajiri S; Kawamata N; Egashira M; Mori K; Oshimi K
Jpn J Cancer Res; 2001 Oct; 92(10):1048-56. PubMed ID: 11676855
[TBL] [Abstract][Full Text] [Related]
59. Alterations of p14
López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C
Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733
[TBL] [Abstract][Full Text] [Related]
60. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients.
Bassi CL; Martelli L; Cipolotti R; Scrideli CA; Defávery R; Tone LG
Braz J Med Biol Res; 2004 Nov; 37(11):1683-7. PubMed ID: 15517085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
